Fusion Antibodies

FAB · AIM · Health Care · mcap £14m · 10.0p

Beta Briefing, track record and bull & bear case are not ready for Fusion Antibodies yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 55 companies are already wired into a briefing: browse them.

Unicorn Asset Management Limited 2 Feb · 1 notice

5.7% → 6.7%

share price at the notices 14.5p · now 10.0p 2 Feb 2026

Maven Capital Partners UK LLP 25 Nov · 1 notice

2.8% → 3.9%

share price at the notices 11.8p · now 10.0p 25 Nov 2025

On October 27 27 Oct · 1 notice

4.2% → 3.9%

share price at the notices 13.8p · now 10.0p 27 Oct 2025

Directors

No open-market share purchases by directors in 12 months.

other Fusion Antibodies plc has issued 308,720 new ordinary shares at 13 pence per share to executive directors Adrian Kinkaid and Richard Buick, satisfying a portion of their bonuses for the year ended March 31, 2025. This is 27 Jan 2026

other Fusion Antibodies plc has announced that its Non-Executive Chair, Simon Douglas, transferred 200,000 ordinary shares of 4 pence each to his daughters for nil consideration. Following this transfer, Mr. Douglas directly h 17 Feb 2026

Company filings. Not investment advice.